HPLC method for determination of in vitro delivery through and into porcine skin of adefovir (PMEA)

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 853, Issue 1-2, 2007, Pages 198-203

  Vávrová, Kateřina ^a   Lorencová, Kateřina ^a   Klimentová, Jana ^a   Novotný, Jakub ^a   Hrabálek, Alexandr ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Acyclic nucleoside phosphonate; Adefovir; Antiviral; Dermal absorption; HPLC UV; Transdermal transport

Indexed keywords

DIFFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH EFFECTS; PHOSPHORUS COMPOUNDS; SKIN; STABILITY;

ACYCLIC NUCLEOSIDE PHOSPHONATES; ADEFOVIR; DERMAL ABSORPTION; TRANSDERMAL TRANSPORT;

DRUG DELIVERY;

ACYCLIC NUCLEOSIDE; ADEFOVIR; MYRISTIC ACID ISOPROPYL ESTER; PHOSPHONIC ACID DERIVATIVE;

ACCURACY; ACIDITY; ALKALINITY; ANIMAL TISSUE; ARTICLE; DIFFUSION; DRUG MONITORING; FRANZ DIFFUSION CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SKIN ABSORPTION; ULTRAVIOLET RADIATION;

ADENINE; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIVIRAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; PHOSPHONIC ACIDS; REPRODUCIBILITY OF RESULTS; SKIN; SKIN ABSORPTION; SPECTROPHOTOMETRY, ULTRAVIOLET; SWINE;

SUS;

EID: 34250020296     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.03.012     Document Type: Article

References (26)

1. Danta M., and Dusheiko G. Int. J. Clin. Pract. 58 (2004) 877
2. Holy A. Curr. Pharm. Des. 9 (2003) 2567
3. Qaqish R.B., Mattes K.A., and Ritchie D.J. Clin. Ther. 25 (2003) 3084
4. Benson H.A. Curr. Drug Deliv. 2 (2005) 23
5. Prausnitz M.R., Mitragotri S., and Langer R. Nat. Rev. Drug Discov. 3 (2004) 115
6. Thomas B.J., and Finnin B.C. Drug Discov. Today 9 (2004) 697
7. De Clercq E., Holy A., and Rosenberg I. Antimicrob. Agents Chemother. 33 (1989) 185
8. De Clercq E., Sakuma T., Baba M., Pauwels R., Balzarini J., Rosenberg I., and Holy A. Antiviral Res. 8 (1987) 261
9. Annaert P., Kinget R., Naesens L., de Clercq E., and Augustijns P. Pharm. Res. 14 (1997) 492
10. Biessen E.A., Valentijn A.R., De Vrueh R.L., Van De Bilt E., Sliedregt L.A., Prince P., Bijsterbosch M.K., Van Boom J.H., Van Der Marel G.A., Abrahams P.J., and Van Berkel T.J. Faseb J. 14 (2000) 1784
11. Rossi L., Serafini S., Cappellacci L., Balestra E., Brandi G., Schiavano G.F., Franchetti P., Grifantini M., Perno C.F., and Magnani M. J. Antimicrob. Chemother. 47 (2001) 819
12. Cundy K.C., Barditch-Crovo P., Walker R.E., Collier A.C., Ebeling D., Toole J., and Jaffe H.S. Antimicrob. Agents Chemother. 39 (1995) 2401
13. Shaw J.P., Louie M.S., Krishnamurthy V.V., Arimilli M.N., Jones R.J., Bidgood A.M., Lee W.A., and Cundy K.C. Drug Metab. Dispos. 25 (1997) 362
14. Sparidans R.W., Veldkamp A., Hoetelmans R.M., and Beijnen J.H. J. Chromatogr. B Biomed. Sci. Appl. 736 (1999) 115
15. Cundy K.C., Shaw J.P., and Lee W.A. Antimicrob. Agents Chemother. 38 (1994) 365
16. Bi H.C., Zhong G.P., Zhou S., Chen X., and Huang M. Rapid Commun. Mass Spectrom. 19 (2005) 2911
17. Liu Y., Xu G., Xu C., Garcia L., Lin C.C., and Yeh L.T. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 803 (2004) 293
18. FDA Guidance for Industry. Bioanalytical Method Validation (2001).
19. Franz T.J. J. Invest. Dermatol. 64 (1975) 190
20. Santoyo S., de Jalon E.G., Campanero M.A., and Ygartua P. J. Pharm. Biomed. Anal. 29 (2002) 819
21. Santoyo S., Ga de Jalon E., Ygartua P., Renedo M.J., and Blanco-Prieto M.J. Int. J. Pharm. 242 (2002) 107
22. Bestman-Smith J., and Boivin G. J. Med. Virol. 67 (2002) 88
23. Perno C.F., Balestra E., Aquaro S., Panti S., Cenci A., Lazzarino G., Tavazzi B., Di Pierro D., Balzarini J., and Calio R. Mol. Pharmacol. 50 (1996) 359
24. Reymen D., Naesens L., Balzarini J., Holy A., Dvorakova H., and De Clercq E. Antiviral Res. 28 (1995) 343
25. Vávrová K., Zbytovská J., and Hrabálek A. Curr. Med. Chem. 12 (2005) 2273
26. Williams A.C., and Barry B.W. Adv. Drug Deliv. Rev. 56 (2004) 603